Tag: Medication safety

FDA: Class I recall of Baxter Clearlink Basic Solution Set with Duovent

Editor's Note The Food and Drug Administration (FDA) on September 15 identified Baxter Healthcare Corporation’s recall of its ClearLink Basic Solution Set with Duovent as Class I, the most serious. The recall was initiated because of the risk for leaks that may expose providers and patients to hazardous toxic substances…

Read More

By: Judy Mathias
September 19, 2022
Share

ECRI, ISMP support World Patient Safety Day, September 17

Editor's Note ECRI and the Institute for Safe Medication Practices (ISMP) announced September 14 that they are joining the World Health Organization and healthcare leaders around the world in celebrating World Patient Safety Day on September 17, 2022. The slogan for this year’s campaign is “Medication without Harm.” In support…

Read More

By: Judy Mathias
September 15, 2022
Share

Efficacy of metformin, ivermectin, fluvoxamine for COVID-19

Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…

Read More

By: Judy Mathias
August 31, 2022
Share

ISMP publishes new perioperative medication safety guidelines

Editor's Note The Institute for Safe Medication Practices (ISMP) on August 11 announced the publication of its first set of safe practice guidelines to support perioperative medication safety in hospitals, ambulatory surgery centers, and other procedural locations. The new guidelines: Address best practices related to labeling and storage of perioperative…

Read More

By: Judy Mathias
August 18, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat